These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

644 related articles for article (PubMed ID: 34736132)

  • 1. Synthesis and in vitro evaluation of chlorogenic acid amides as potential hypoglycemic agents and their synergistic effect with acarbose.
    Cardullo N; Floresta G; Rescifina A; Muccilli V; Tringali C
    Bioorg Chem; 2021 Dec; 117():105458. PubMed ID: 34736132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of obovatol and related neolignan analogues as α-glucosidase and α-amylase inhibitors.
    Sciacca C; Cardullo N; Pulvirenti L; Travagliante G; D'Urso A; D'Agata R; Peri E; Cancemi P; Cornu A; Deffieux D; Pouységu L; Quideau S; Muccilli V
    Bioorg Chem; 2024 Jun; 147():107392. PubMed ID: 38723423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unveiling anti-diabetic potential of new thiazole-sulfonamide derivatives: Design, synthesis, in vitro bio-evaluation targeting DPP-4, α-glucosidase, and α-amylase with in-silico ADMET and docking simulation.
    Khamees Thabet H; Ammar YA; Imran M; Hamdy Helal M; Ibrahim Alaqel S; Alshehri A; Ash Mohd A; Abusaif MS; Ragab A
    Bioorg Chem; 2024 Oct; 151():107671. PubMed ID: 39067419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alpha-Amylase and Alpha-Glucosidase Enzyme Inhibition and Antioxidant Potential of 3-Oxolupenal and Katononic Acid Isolated from
    Alqahtani AS; Hidayathulla S; Rehman MT; ElGamal AA; Al-Massarani S; Razmovski-Naumovski V; Alqahtani MS; El Dib RA; AlAjmi MF
    Biomolecules; 2019 Dec; 10(1):. PubMed ID: 31905962
    [No Abstract]   [Full Text] [Related]  

  • 5. Furofuran lignans as a new series of antidiabetic agents exerting α-glucosidase inhibition and radical scarvenging: Semisynthesis, kinetic study and molecular modeling.
    Worawalai W; Doungwichitrkul T; Rangubpit W; Taweechat P; Sompornpisut P; Phuwapraisirisan P
    Bioorg Chem; 2019 Jun; 87():783-793. PubMed ID: 30978603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A facile approach synthesis of benzoylaryl benzimidazole as potential α-amylase and α-glucosidase inhibitor with antioxidant activity.
    Aroua LM; Almuhaylan HR; Alminderej FM; Messaoudi S; Chigurupati S; Al-Mahmoud S; Mohammed HA
    Bioorg Chem; 2021 Sep; 114():105073. PubMed ID: 34153810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of novel 6-(piperidin-1-ylsulfonyl)-2H-chromenes targeting α-glucosidase, α-amylase, and PPAR-γ: Design, synthesis, virtual screening, and anti-diabetic activity for type 2 diabetes mellitus.
    Thabet HK; Abusaif MS; Imran M; Helal MH; Alaqel SI; Alshehri A; Mohd AA; Ammar YA; Ragab A
    Comput Biol Chem; 2024 Aug; 111():108097. PubMed ID: 38772048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel acyl hydrazide derivatives of polyhydroquinoline as potent anti-diabetic and anti-glycating agents: Synthesis, in vitro α-amylase, α-glucosidase inhibition and anti-glycating activity with molecular docking insights.
    Ur Rahman S; Alam A; Parveen Z; Zainab ; Assad M; Adnan Ali Shah S; Rafiq H; Ayaz M; Latif A; Naveed Umar M; Ali M; Ahmad M
    Bioorg Chem; 2024 Sep; 150():107501. PubMed ID: 38865858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multicomponent reaction for the synthesis of new 1,3,4-thiadiazole-thiazolidine-4-one molecular hybrids as promising antidiabetic agents through α-glucosidase and α-amylase inhibition.
    Gummidi L; Kerru N; Ebenezer O; Awolade P; Sanni O; Islam MS; Singh P
    Bioorg Chem; 2021 Oct; 115():105210. PubMed ID: 34332231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of new anti-diabetic potential agents based on paracetamol incorporating sulfa-drugs: Design, synthesis, α-amylase, and α-glucosidase inhibitors with molecular docking simulation.
    Khamees Thabet H; Ragab A; Imran M; Helal MH; Ibrahim Alaqel S; Alshehri A; Ash Mohd A; Rakan Alshammari M; S Abusaif M; A Ammar Y
    Eur J Med Chem; 2024 Sep; 275():116589. PubMed ID: 38878516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel molecular hybrids of EGCG and quinoxaline: Potent multi-targeting antidiabetic agents that inhibit α-glucosidase, α-amylase, and oxidative stress.
    Kothari M; Kannan K; Sahadevan R; Sadhukhan S
    Int J Biol Macromol; 2024 Apr; 263(Pt 1):130175. PubMed ID: 38360242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel enantiopure isoxazolidine and C-alkyl imine oxide derivatives as potential hypoglycemic agents: Design, synthesis, dual inhibitors of α-amylase and α-glucosidase, ADMET and molecular docking study.
    Ghannay S; Snoussi M; Messaoudi S; Kadri A; Aouadi K
    Bioorg Chem; 2020 Nov; 104():104270. PubMed ID: 32947132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of azachalcones, their α-amylase, α-glucosidase inhibitory activities, kinetics, and molecular docking studies.
    Saleem F; Kanwal ; Khan KM; Chigurupati S; Solangi M; Nemala AR; Mushtaq M; Ul-Haq Z; Taha M; Perveen S
    Bioorg Chem; 2021 Jan; 106():104489. PubMed ID: 33272713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Curcumin-based Antioxidant and Glycohydrolase Inhibitor Compounds: Synthesis and In Vitro Appraisal of the Dual Activity Against Diabetes.
    Esmaeili S; Ghobadi N; Nazari D; Pourhossein A; Rasouli H; Adibi H; Khodarahmi R
    Med Chem; 2021; 17(7):677-698. PubMed ID: 32370719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic effect of potential alpha-amylase inhibitors from Egyptian propolis with acarbose using in silico and in vitro combination analysis.
    Nada AA; Metwally AM; Asaad AM; Celik I; Ibrahim RS; Eldin SMS
    BMC Complement Med Ther; 2024 Jan; 24(1):65. PubMed ID: 38291462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel cinnamic acid magnolol derivatives as potent α-glucosidase and α-amylase inhibitors: Synthesis, in vitro and in silico studies.
    Hu CM; Wang WJ; Ye YN; Kang Y; Lin J; Wu PP; Li DL; Bai LP; Xu XT; Li BQ; Zhang K
    Bioorg Chem; 2021 Nov; 116():105291. PubMed ID: 34438122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A trisaccharide phenylethanoid glycoside from Scrophularia flava Grau with potential anti-type 2 diabetic properties by inhibiting α-glucosidase enzyme and decreasing oxidative stress.
    Hamedi A; Pasdaran A; Pasdaran A
    Bioorg Chem; 2020 Jun; 99():103776. PubMed ID: 32276136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of new clioquinol derivatives as potent α-glucosidase inhibitors; molecular docking, kinetic and structure-activity relationship studies.
    Wali S; Atia-Tul-Wahab ; Ullah S; Khan MA; Hussain S; Shaikh M; Atta-Ur-Rahman ; Choudhary MI
    Bioorg Chem; 2022 Feb; 119():105506. PubMed ID: 34896920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. α-Glucosidase inhibition assay of galbanic acid and it amide derivatives: New excellent semi-synthetic α-glucosidase inhibitors.
    Mohammadi-Khanaposhtani M; Sayahi MH; Yazzaf R; Dastyafteh N; Halimi M; Iraji A; Dadgar A; Mojtabavi S; Faramarzi MA; Palimi M; Mirzazadeh R; Larijani B; Delnavazi MR; Mahdavi M
    Bioorg Chem; 2024 Sep; 150():107580. PubMed ID: 38959646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tyramine Derivatives as Potent Therapeutics for Type 2 Diabetes: Synthesis and
    Bashir MA; Javaid K; Shaikh M; Choudhary MI; Siddiqui H
    Med Chem; 2020; 16(8):1124-1135. PubMed ID: 32003674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.